Introduction {#sec1-1}
============

Peristomal inflammation often develops in patients with ureterocutaneostomy or ileal conduit.[@ref1] The inflammation presumably results from direct irritation by urinary contents, allergic reaction to stomal devices, regional infection, or abrasion. The case reported here showed persistent inflammation including erythematous, erosive, eczematous, and pruritic lesions in the peripheral region of the ureterocutaneostomy stoma. A pagetoid variant of urothelial carcinoma (UC) recurred in the upper urinary tract and spread to the peristomal skin, with a skin appearance similar to that in Paget's disease. To the best of our knowledge, there have been no reports of a peristomal Paget phenomenon in UC patients who underwent ureterocutaneostomy or ileal conduit, and only one report of a similar phenomenon in a patient who underwent ileostomy for ulcerative colitis.[@ref2] However, urologists may overlook Paget phenomenon as simple peristomal inflammation, and thus cases with such a lesion may be latently larger in number than expected. Therefore, we describe this case to increase awareness of the possibility of this phenomenon in association with a peristomal lesion.

Case Report {#sec1-2}
===========

The patient was a 69-year-old female who developed macroscopic hematuria 7 years ago. Under clinical diagnosis of bladder carcinoma, she underwent transurethral resection, with a resultant pathological diagnosis of urothelial carcinoma in situ (CIS). Two years later, she developed recurrence of stage Tis UC in the most distal part of the left ureter and underwent left nephroureterectomy. One year later, she had intravesical recurrence of UC as stage Tis disease with resistance to BCG therapy and underwent radical cystectomy and reconstruction with ureterocutaneostomy. Two years ago, peristomal inflammation developed and persisted despite regular medication for dermatitis.

Two dermatologists (S.I. and M.T.) suspected squamous cell carcinoma or metastatic skin carcinoma by inspection and performed peristomal skin biopsy. Under a diagnosis of a peristomal Paget phenomenon of UC, we performed *en-bloc* resection of the remaining ureter and peristomal skin with a sufficient normal margin ([Figure 1](#fig001){ref-type="fig"}) and percutaneous nephrostomy, followed by reconstruction of the abdominal wall to wrap the exposed fascia with surrounding excess skin.

Pagetoid cells and conventional CIS cells were observed by light microscopy in the distal two-thirds of the right ureter. The pagetoid cells formed a cluster and had spread to basal layers of transitional epithelium with partial squamous metaplasia. These cells were characterized by abundant clear cytoplasm with occasional vacuoles, enlarged hyperchromatic nuclei and overt nucleoli. Pagetoid cells had also spread into the peristomal epidermis directly from the ureteral mucosa ([Figure 2a](#fig002){ref-type="fig"}) and were present among p63-positive cells (*i.e.* epidermal basal cells), which showed that pagetoid cells had spread to the basal layer of the epidermis. However, the basal membrane between the epidermis and dermis was intact and the tumor cells had not invaded the dermis. The intraepidermal pagetoid cells had abundant mitoses and formed a papillary or pseudoalveolar architecture. The surrounding stroma showed prominent congestion and infiltration of lymphocytes and histiocytes, but neither via-vessel extension nor direct invasion of neoplastic cells ([Figure 2b](#fig002){ref-type="fig"}). In immunohistochemistry, the cells in the epidermis and ureteral mucosa were positive for CK7 and CK20 ([Figure 2c](#fig002){ref-type="fig"}) and pagetoid cells were positive for HER2 ([Figure 2c](#fig002){ref-type="fig"}). In contrast to the distal region, the proximal surgical end of the ureter was free of cancerous cells.

Discussion and Conclusions {#sec1-3}
==========================

In this report, we presented a case in which a pagetoid variant of UC derived from the ureter after ureterocutaneostomy spread to the skin of the peripheral region of a ureterocutaneostomy stoma, with a resulting appearance that resembled Paget's disease. Pagetoid growth of UC is one phenotype of urothelial carcinoma *in situ* (CIS), which was first described in 1952 by Melicow *et al*.[@ref3] Among bladder CIS cases, 12-16% involve pagetoid change.^[@ref4],[@ref5]^ However, cases with pagetoid spread of UC to the skin are rare, and there have been only a few reports of UC of the bladder that spread to the skin, including the glans penis, urethral meatus, and vulva.[@ref6] In such cases, discrimination of a perineal pagetoid lesion of UC from primary extramammary Paget's disease requires immunohistochemistry with antibodies against CK7, CK20, Mucin, PAS, CEA and GCDFP15.^[@ref6]-[@ref9]^

In our case, the previously extirpated left ureter and bladder had conventional CIS without pagetoid change. Therefore, pagetoid UC cells may have newly developed from CIS in the remaining right ureter and spread to the peristomal skin. UC of the upper urinary tract often recurs in the downstream portion (*i.e.* the bladder), presumably due to tumor implantation.[@ref10] In our case, however, metastasis of pagetoid UC cells to the peristomal skin may not have occurred through implantation or viavessel extension, but by direct invasion, based on the pathological findings. Interestingly, UC cells that spread to urinary skin downstream have had a pagetoid phenotype in previous reports, and this was also found in our case. This suggests that UC cells with a pagetoid phenotype have closer affinity with skin than those with a conventional phenotype. The pagetoid UC cells in our case were positive for HER2, via which a motility factor is believed to induce epidermal spread of Paget's cells in Paget's disease.[@ref11]

The differential diagnosis for the pagetoid lesion was relatively easy in our patient because her lesion was distant from predilection sites for mammary or extramammary Paget's disease, such as the nipple, axilla, external genitalia, anus and umbilicus. Immunohistochemistry also showed that the pagetoid cells were positive for CK7 and CK20, and negative for mucin, PAS and CEA (data not shown), which classified the lesion as secondary Paget's disease.^[@ref7],[@ref8]^

Urologists sometimes encounter recurrence of UC from the urothelium itself at the stoma, but it may be difficult for general urologists with limited expertise in dermatology to distinguish epidermal spread of pagetoid UC, especially at an early stage, from incurable peristomal inflammation based on gross appearance alone. The case reported here has no precedent in the English literature, which implies that spread of pagetoid UC to peristomal skin is rare. However, such a malignant lesion might be overlooked as simple inflammation. Therefore, urologists should bear in mind the possible phenotype of UC spread in a patient with persistent peristomal inflammation. In such a case, a dermatologist should be consulted for a skin biopsy.

![Gross appearances of (a) peristomal skin lesion and (b) *en-bloc* extirpated specimen including the peristomal skin and right ureter (b). The peristomal skin included erythematous, erosive, eczematous and circinate lesions, which resembled Paget's disease, but the surgical margin was free from these lesions. The ureter cut open showed extensive roughness on the mucosal surface. \*means exit of the right ureter, † means navel, ▲means planned resection line.](rt-2013-3-e49-g001){#fig001}

![Light microscopic appearance of pagetoid lesions. (a) Junction of the right ureter and peristomal skin. Most of the junction was eroded. In the residual intact junction, pagetoid cells spread into the peristomal epidermis directly from the ureteral mucosa. (hematoxylin-eosin stain, 4× and 100×). (b) Intraepidermal pagetoid lesion in the peristomal skin. (hematoxylin-eosin stain, 40× and 200×). (c) Immunohistochemistry with anti-HER2, anti-CK7 or anti-CK20 antibody. The presence of both CK7 and CK20 is characteristic of secondary Paget's disease. Expression of HER2 implies an epidermotropic ability of pagetoid tumor cells (hematoxylin-eosin or immunoperoxidase stain, 40×).](rt-2013-3-e49-g002){#fig002}
